Reducing Antibacterial Development Risk for GSK1322322 by Exploring Potential Human Dose Regimens in Nonclinical Efficacy Studies Using Immunocompetent Rats

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00959-17
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology


Related search